Global Letermovir Injection Market Growth 2026-2032

September 2026 | 80 pages | ID: G7ECCCE8FF41EN
LP Information

Abstracts

The global Letermovir Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Letermovir Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Letermovir Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Letermovir Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Letermovir Injection players cover Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Letermovir Injection Industry Forecast” looks at past sales and reviews total world Letermovir Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Letermovir Injection sales for 2026 through 2032. With Letermovir Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Letermovir Injection industry.

This Insight Report provides a comprehensive analysis of the global Letermovir Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Letermovir Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Letermovir Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Letermovir Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Letermovir Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Letermovir Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 240 mg/12 mL (20 mg/mL)
• 480 mg/24 mL (20 mg/mL)

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Letermovir Injection market?
• What factors are driving Letermovir Injection market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Letermovir Injection market opportunities vary by end market size?
• How does Letermovir Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Letermovir Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Letermovir Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Letermovir Injection by Country/Region, 2021, 2025 & 2032
  2.2 Letermovir Injection Segment by Type
  2.2.1 240 mg/12 mL (20 mg/mL)
  2.2.2 480 mg/24 mL (20 mg/mL)
  2.2.3 Letermovir Injection Sales by Type
  2.2.3.1 Global Letermovir Injection Sales Market Share by Type (2021-2026)
  2.2.3.2 Global Letermovir Injection Revenue and Market Share by Type (2021-2026)
  2.2.3.3 Global Letermovir Injection Sale Price by Type (2021-2026)
  2.3 Letermovir Injection Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Letermovir Injection Sales by Application
  2.3.4.1 Global Letermovir Injection Sale Market Share by Application (2021-2026)
  2.3.4.2 Global Letermovir Injection Revenue and Market Share by Application (2021-2026)
  2.3.4.3 Global Letermovir Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Letermovir Injection Breakdown Data by Company
  3.1.1 Global Letermovir Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Letermovir Injection Sales Market Share by Company (2021-2026)
  3.2 Global Letermovir Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Letermovir Injection Revenue by Company (2021-2026)
  3.2.2 Global Letermovir Injection Revenue Market Share by Company (2021-2026)
  3.3 Global Letermovir Injection Sale Price by Company
  3.4 Key Manufacturers Letermovir Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Letermovir Injection Product Location Distribution
  3.4.2 Players Letermovir Injection Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LETERMOVIR INJECTION BY GEOGRAPHIC REGION

  4.1 World Historic Letermovir Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Letermovir Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Letermovir Injection Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Letermovir Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Letermovir Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Letermovir Injection Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Letermovir Injection Sales Growth
  4.4 APAC Letermovir Injection Sales Growth
  4.5 Europe Letermovir Injection Sales Growth
  4.6 Middle East & Africa Letermovir Injection Sales Growth

5 AMERICAS

  5.1 Americas Letermovir Injection Sales by Country
  5.1.1 Americas Letermovir Injection Sales by Country (2021-2026)
  5.1.2 Americas Letermovir Injection Revenue by Country (2021-2026)
  5.2 Americas Letermovir Injection Sales by Type (2021-2026)
  5.3 Americas Letermovir Injection Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Letermovir Injection Sales by Region
  6.1.1 APAC Letermovir Injection Sales by Region (2021-2026)
  6.1.2 APAC Letermovir Injection Revenue by Region (2021-2026)
  6.2 APAC Letermovir Injection Sales by Type (2021-2026)
  6.3 APAC Letermovir Injection Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Letermovir Injection by Country
  7.1.1 Europe Letermovir Injection Sales by Country (2021-2026)
  7.1.2 Europe Letermovir Injection Revenue by Country (2021-2026)
  7.2 Europe Letermovir Injection Sales by Type (2021-2026)
  7.3 Europe Letermovir Injection Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Letermovir Injection by Country
  8.1.1 Middle East & Africa Letermovir Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Letermovir Injection Revenue by Country (2021-2026)
  8.2 Middle East & Africa Letermovir Injection Sales by Type (2021-2026)
  8.3 Middle East & Africa Letermovir Injection Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Letermovir Injection
  10.3 Manufacturing Process Analysis of Letermovir Injection
  10.4 Industry Chain Structure of Letermovir Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Letermovir Injection Distributors
  11.3 Letermovir Injection Customer

12 WORLD FORECAST REVIEW FOR LETERMOVIR INJECTION BY GEOGRAPHIC REGION

  12.1 Global Letermovir Injection Market Size Forecast by Region
  12.1.1 Global Letermovir Injection Forecast by Region (2027-2032)
  12.1.2 Global Letermovir Injection Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Letermovir Injection Forecast by Type (2027-2032)
  12.7 Global Letermovir Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Letermovir Injection Product Portfolios and Specifications
  13.1.3 Merck Letermovir Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Letermovir Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Letermovir Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 240 mg/12 mL (20 mg/mL)
Table 4. Major Players of 480 mg/24 mL (20 mg/mL)
Table 5. Global Letermovir Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Letermovir Injection Sales Market Share by Type (2021-2026)
Table 7. Global Letermovir Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Letermovir Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Letermovir Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Letermovir Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Letermovir Injection Sale Market Share by Application (2021-2026)
Table 12. Global Letermovir Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Letermovir Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Letermovir Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Letermovir Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Letermovir Injection Sales Market Share by Company (2021-2026)
Table 17. Global Letermovir Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Letermovir Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Letermovir Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Letermovir Injection Producing Area Distribution and Sales Area
Table 21. Players Letermovir Injection Products Offered
Table 22. Letermovir Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Letermovir Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Letermovir Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Letermovir Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Letermovir Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Letermovir Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Letermovir Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Letermovir Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Letermovir Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Letermovir Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Letermovir Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Letermovir Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Letermovir Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Letermovir Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Letermovir Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Letermovir Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Letermovir Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Letermovir Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Letermovir Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Letermovir Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Letermovir Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Letermovir Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Letermovir Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Letermovir Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Letermovir Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Letermovir Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Letermovir Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Letermovir Injection
Table 52. Key Market Challenges & Risks of Letermovir Injection
Table 53. Key Industry Trends of Letermovir Injection
Table 54. Letermovir Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Letermovir Injection Distributors List
Table 57. Letermovir Injection Customer List
Table 58. Global Letermovir Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Letermovir Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Letermovir Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Letermovir Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Letermovir Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Letermovir Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Letermovir Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Letermovir Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Letermovir Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Letermovir Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Letermovir Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Letermovir Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Letermovir Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Letermovir Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Letermovir Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Letermovir Injection Product Portfolios and Specifications
Table 74. Merck Letermovir Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Letermovir Injection
Figure 2. Letermovir Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Letermovir Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Letermovir Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Letermovir Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Letermovir Injection Sales Market Share by Country/Region (2025)
Figure 10. Letermovir Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 240 mg/12 mL (20 mg/mL)
Figure 12. Product Picture of 480 mg/24 mL (20 mg/mL)
Figure 13. Global Letermovir Injection Sales Market Share by Type in 2026
Figure 14. Global Letermovir Injection Revenue Market Share by Type (2021-2026)
Figure 15. Letermovir Injection Consumed in Hospital
Figure 16. Global Letermovir Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. Letermovir Injection Consumed in Clinic
Figure 18. Global Letermovir Injection Market: Clinic (2021-2026) & (K Units)
Figure 19. Letermovir Injection Consumed in Other
Figure 20. Global Letermovir Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Letermovir Injection Sale Market Share by Application (2025)
Figure 22. Global Letermovir Injection Revenue Market Share by Application in 2026
Figure 23. Letermovir Injection Sales by Company in 2026 (K Units)
Figure 24. Global Letermovir Injection Sales Market Share by Company in 2026
Figure 25. Letermovir Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Letermovir Injection Revenue Market Share by Company in 2026
Figure 27. Global Letermovir Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Letermovir Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Letermovir Injection Sales 2021-2026 (K Units)
Figure 30. Americas Letermovir Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Letermovir Injection Sales 2021-2026 (K Units)
Figure 32. APAC Letermovir Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Letermovir Injection Sales 2021-2026 (K Units)
Figure 34. Europe Letermovir Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Letermovir Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Letermovir Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Letermovir Injection Sales Market Share by Country in 2026
Figure 38. Americas Letermovir Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Letermovir Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Letermovir Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Letermovir Injection Sales Market Share by Region in 2026
Figure 46. APAC Letermovir Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Letermovir Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Letermovir Injection Sales Market Share by Application (2021-2026)
Figure 49. China Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Letermovir Injection Sales Market Share by Country in 2026
Figure 57. Europe Letermovir Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Letermovir Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Letermovir Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Letermovir Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Letermovir Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Letermovir Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Letermovir Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Letermovir Injection in 2026
Figure 74. Manufacturing Process Analysis of Letermovir Injection
Figure 75. Industry Chain Structure of Letermovir Injection
Figure 76. Channels of Distribution
Figure 77. Global Letermovir Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Letermovir Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Letermovir Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Letermovir Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Letermovir Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Letermovir Injection Revenue Market Share Forecast by Application (2027-2032)